Clinical Trial

Clinical Use Study of SAPH Device for Patent Hemostasis After a Transradial Procedure

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2025 (before its estimated October 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter study intended to provide supportive clinical information on the use of the SAPH device to achieve radial artery patent hemostasis after a transradial procedure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Trial Details
NCT Number NCT06991010
Lead Sponsor Transradial Technologies, LLC
Collaborators: RARAS CRO
Conditions Hemostasis of Arterial Punctures
Enrollment 50 participants
Start Date 2025-08-01
Primary Completion 2025-10-28 (estimated)
Study Completion 2025-11-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-15